Peroxitech Awarded NIH Grant to Develop a Novel Therapeutic Approach to Expend and Improve Lung Transplant Organ Pool

Philadelphia – August 30, 2022 – Peroxitech Inc., an emerging biopharmaceutical company, has been awarded an NIH grant to further develop a novel therapeutic treatment to extend and improve the storage and viability of donor lungs for transplant.

​Peroxitech Awarded NIH Grant to Develop a Novel Therapeutic Compound for Acute Lung Injury

Philadelphia – June 1, 2020 – Peroxitech Inc., an emerging biopharmaceutical company, has been awarded an NIH grant to continue development of a novel therapeutic compound for the treatment of Acute Lung Injury (ALI).